Discussion We examined the experiences of patients with obesity or T2D attending medical weight management or community diabetes service respectively, who were prescribed a GLP-1 receptor agonist, with respect to changes in their mental health including eating behaviours
Alterations and fluctuations in gut microbiota and its metabolites appear to promote development and maintenance of IBS symptoms

As Colorado has state-supervised, county-administered benefits assistance, we are collaborating with the Colorado Department of Human Services and counties to improve eligibility and application processes: Improving our systems that support members, applicants and eligibility workers including improvements to PEAK, the online member-facing portal for applications and renewals, and improvements to the back end system that eligibility workers use called the Colorado Benefits Management System (CBMS) Streamlining and standardizing eligibility processes to increase quality and consistency for service across counties through Joint Agency Interoperability Exploring policies and a new funding model for county administration as authorized by County Administration of Public Assistance Programs (SB22-235) We are updating our member correspondence to improve clarity, and continuing to increase renewal automation (ex parte) and digital renewal (PEAK) capabilities

The FDA warns that some patients and health care professionals may look to unapproved versions of GLP-1 (glucagon-like peptide-1 (GLP-1) receptor agonists) drugs for weight loss, potentially exposing consumers to counterfeit or unsafe products
Hers is the women-focused branch of Hims & Hers Health, Inc., which originally launched as Hims, a telehealth platform for people who identify as men